Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 5/20 | 0.68 |
| ▸ | MAPT | P10636 | 4/20 | 0.68 |
| ▸ | PKM | P14618 | 3/20 | 0.68 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.68 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.68 |
| ▸ | APEX1 | P27695 | 2/20 | 0.68 |
| ▸ | POLB | P06746 | 2/20 | 0.68 |
| ▸ | GAA | P10253 | 2/20 | 0.68 |
| ▸ | INPPL1 | O15357 | 1/20 | 0.68 |
| ▸ | ALPL | P05186 | 1/20 | 0.68 |
| ▸ | ALPI | P09923 | 1/20 | 0.68 |
| ▸ | ALPG | P10696 | 1/20 | 0.68 |
| ▸ | RECQL | P46063 | 1/20 | 0.68 |
| ▸ | BLM | P54132 | 1/20 | 0.68 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.68 |
| ▸ | PFKFB3 | Q16875 | 1/20 | 0.68 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.68 |
| ▸ | PPARG | P37231 | 1/20 | 0.61 |
| ▸ | CDK5 | Q00535 | 2/20 | 0.57 |
| ▸ | CDK5R1 | Q15078 | 2/20 | 0.57 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30269735 | 1.00 | KMT2A (0.68) | KMT2AMAPTPKMKDM4ETDP1 | |
| SCHEMBL10013320 | 0.88 | ABCB1 (0.64) | KMT2AMAPTPKMKDM4ETDP1 | |
| SCHEMBL28009934 | 0.86 | TERT (0.58) | KMT2AMAPTKDM4ETDP1POLB | |
| Sideroxylin SCHEMBL28397284 | 0.85 | PPARG (0.73) | KMT2AMAPTPKMKDM4ETDP1 | |
| SCHEMBL14066713 | 0.82 | CBS (0.74) | KMT2AMAPTPKMKDM4ETDP1 | |
| SCHEMBL14053704 | 0.81 | KMT2A (1.00) | KMT2AMAPTPKMKDM4ETDP1 | |
| SCHEMBL29974497 | 0.81 | KMT2A (1.00) | KMT2AMAPTPKMKDM4ETDP1 | |
| SCHEMBL3320910 | 0.81 | ALDH1A1 (0.70) | KMT2AMAPTKDM4EPOLBGAA | |
| SCHEMBL30956242 | 0.81 | ALDH1A1 (0.70) | KMT2AMAPTKDM4EPOLBGAA | |
| SCHEMBL18462964 | 0.81 | AR (0.57) | KMT2AMAPTPKMKDM4ETDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119969266-A | In-vitro culture and rapid propagation method of chlorophytum comosum | 广东省农业科学院作物研究所 | 2025-05-13 | — | — | CN | disclosed |
| US-11786503-B2 | Pharmaceutical compositions and methods for countering chemotherapy induced cardiotoxicity | AURANSA INC. (US) | 2023-10-17 | — | — | US | disclosed |
| US-20220133684-A1 | PHARMACEUTICAL COMPOSITIONS AND METHODS FOR COUNTERING CHEMOTHERAPY INDUCED CARDIOTOXICITY | AURANSA INC. (US) | 2022-05-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11786503-B2 | Pharmaceutical compositions and methods for countering chemotherapy induced cardiotoxicity | RDX, TNNT2, CHLSN | KMT2A 1476/4885MAPT 4042/4885PKM 2865/4885 |
| US-20220133684-A1 | PHARMACEUTICAL COMPOSITIONS AND METHODS FOR COUNTERING CHEMOTHERAPY INDUCED CARDIOTOXICITY | RDX, TNNT2, CHLSN | KMT2A 1476/4885MAPT 4042/4885PKM 2865/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.